Genetic dissection of intratumor heterogeneity of PD-L1 expression in EGFR-mutated lung adenocarcinoma

被引:2
|
作者
Kunimasa, Kei [1 ]
Hirotsu, Yosuke [2 ]
Amemiya, Kenji [2 ]
Honma, Keiichiro [3 ]
Nakamura, Harumi [4 ]
Nishino, Kazumi [1 ]
Omata, Masao [2 ,5 ]
机构
[1] Osaka Int Canc Inst, Dept Thorac Oncol, 3-1-69 Otemae Chuoku, Osaka, Osaka 5418567, Japan
[2] Yamanashi Cent Hosp, Genome Anal Ctr, Kofu, Yamanashi, Japan
[3] Osaka Int Canc Inst, Dept Diagnost Pathol & Cytol, Osaka, Japan
[4] Osaka Int Canc Inst, Lab Genom Pathol, Osaka, Japan
[5] Univ Tokyo, Tokyo, Japan
基金
日本学术振兴会;
关键词
EGFR mutation; intratumor heterogeneity; PD-L1; expression; tumor infiltrating lymphocytes; MUTATIONS; GENOME; CELLS;
D O I
10.1111/1759-7714.15038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we investigated the association between PD-L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next-generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD-L1 expression, the EGFR major activating mutation was selected as the most frequent driver mutation. Surgical resection specimens were used to extract sufficient amounts of nucleic acids for analysis, and the high tumor proportion score (TPS:100%) and low (TPS: 0%) PD-L1-expressing parts of the tumor were each laser microdissected to examine the association between PD-L1 expression heterogeneity and genetic mutations within the same tumor. The association between PD-L1 heterogeneity and gene mutations within the same tumor was investigated. Analysis showed no association between PD-L1 expression heterogeneity and genetic variants, which were found to be almost identical. However, PD-L1 expression was found to be associated with the number of tumor infiltrating lymphocytes (TILs) present in the tumor, which may be related to whether or not lymphocytes can infiltrate into the tumor depending on the tumor histological type (solid pattern, lepidic pattern, etc.) and other factors.
引用
收藏
页码:2210 / 2215
页数:6
相关论文
共 50 条
  • [21] The Effect of Pembrolizumab In EGFR Mutated Lung Adenocarcinoma Patients With PD-L1 Overexpression: Two Cases Report
    Uenami, T.
    Ishijima, M.
    Kanazu, M.
    Kurebe, H.
    Edahiro, R.
    Nishida, K.
    Akazawa, Y.
    Yano, Y.
    Yamaguchi, T.
    Mori, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1035 - S1036
  • [22] Prognostic Impact of PD-L1 Expression on EGFR Tyrosine Kinase Inhibition in Lung Adenocarcinoma
    Kang, M.
    Kim, S. H.
    Yoon, S. W.
    Suh, K. J.
    Kim, Y. J.
    Ock, C.
    Kim, M.
    Keam, B.
    Kim, T. M.
    Heo, D. S.
    Lee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S381 - S382
  • [23] The Association of PD-L1 Expression with Clinical Characteristics and EGFR and ALK Status in Lung Adenocarcinoma
    Wang, J.
    Wu, S.
    Shi, X.
    Liu, Y.
    Zeng, X.
    Zhou, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2109 - S2109
  • [24] Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
    Jacob H. Rasmussen
    Giedrius Lelkaitis
    Katrin Håkansson
    Ivan R. Vogelius
    Helle H. Johannesen
    Barbara M. Fischer
    Søren M. Bentzen
    Lena Specht
    Claus A. Kristensen
    Christian von Buchwald
    Irene Wessel
    Jeppe Friborg
    British Journal of Cancer, 2019, 120 : 1003 - 1006
  • [25] Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
    Rasmussen, Jacob H.
    Lelkaitis, Giedrius
    Hakansson, Katrin
    Vogelius, Ivan R.
    Johannesen, Helle H.
    Fischer, Barbara M.
    Bentzen, Soren M.
    Specht, Lena
    Kristensen, Claus A.
    von Buchwald, Christian
    Wessel, Irene
    Friborg, Jeppe
    BRITISH JOURNAL OF CANCER, 2019, 120 (10) : 1003 - 1006
  • [26] Heterogeneity and Geographical Patterns of PD-L1 Expression in Colonic Adenocarcinoma with Discordant PD-L1 Status
    Messersmith, Lynn
    Williams, Grant
    Bohan, Phillip Kemp
    Chick, Robert
    Broadwater, Devin
    Lombardo, Jamie
    Hickerson, Annelies
    Cindass, Jessica
    Brady, Robert
    Peoples, George
    Clifton, Guy
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 716 - 717
  • [27] Heterogeneity and Geographical Patterns of PD-L1 Expression in Colonic Adenocarcinoma with Discordant PD-L1 Status
    Messersmith, Lynn
    Williams, Grant
    Bohan, Phillip Kemp
    Chick, Robert
    Broadwater, Devin
    Lombardo, Jamie
    Hickerson, Annelies
    Cindass, Jessica
    Brady, Robert
    Peoples, George
    Clifton, Guy
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 716 - 717
  • [28] PATIENTS WITH EGFR-MUTATED LUNG ADENOCARCINOMA AFTER PROGRESSION
    Li, Ling
    Tian, Jiyuan
    Sun, Haiyan
    ACTA MEDICA MEDITERRANEA, 2023, 39 (03): : 707 - 713
  • [29] Prognostic factors of EGFR-mutated metastatic adenocarcinoma of lung
    Sing, Ng Kwok
    Sun, Chu King
    Ting, Kung Boom
    Kun, Au Yong Ting
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 123
  • [30] Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma
    Torasawa, Masahiro
    Yoshida, Tatsuya
    Shiraishi, Kouya
    Yagishita, Shigehiro
    Ono, Hanako
    Uehara, Yuji
    Miyakoshi, Jun
    Tateishi, Akiko
    Igawa, Yukiko Shimoda
    Higashiyama, Ryoko Inaba
    Mochizuki, Akifumi
    Masuda, Ken
    Matsumoto, Yuji
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Hamamoto, Ryuji
    Yamamoto, Noboru
    Watanabe, Shun-ichi
    Yatabe, Yasushi
    Takahashi, Kazuhisa
    Kohno, Takashi
    Ohe, Yuichiro
    LUNG CANCER, 2025, 202